Project Grant HT94252510997
Award Date 11/1/25
Completion Date 10/31/28
Dollars Obligated $722K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Australia
Similar Awards
- The Defense Health Agency awarded a $4,319,388 Project Grant to the University of Melbourne to fund research aimed at "TARGETING SENESCENT CELLS TO IMPROVE OUTCOMES FOR BREAST CANCER PATIENTS" over the period from September 1, 2024 to August 31, 2028. This grant is provided under the Military Medical Research and Development Program (CFDA 12.420), which supports biomedical research to improve the health and care of military service members, veterans, and their families. The...
- The University of Melbourne was awarded a $591,778 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420) to conduct research aimed at "Harnessing the Immune Response in Exceptionally Long-Term Survivors to Develop Novel Therapeutics." The project will run from May 1, 2024 to April 30, 2027. The University of Melbourne has a history of conducting federal research and consulting work in areas such as...
- The University of Melbourne received a $389,161 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to support research on "The Linkage of Neuroendocrine, Neurovascular, and Metabolic Factors in ME/CFS". The award period runs from February 1, 2025 to January 31, 2027. The University of Melbourne, a prominent international academic institution in Australia, will conduct advanced biomedical research to investigate...
- This federal Project Grant award in the amount of $733,068.00 was issued by the Defense Health Agency to the University of Melbourne on September 1, 2023 under the Military Medical Research and Development program (CFDA 12.420). The funding will support a 3-year research project titled "Investigating Transcript Diversity as a Driver of Melanoma Progression and Recurrence." The University of Melbourne will conduct basic, translational, and clinical research aimed at developing new...
- This Project Grant award from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) is providing $968,717.00 to the University of Melbourne to conduct research aimed at solving a major complication of Parkinson's disease - debilitating constipation. The research will utilize novel pharmacology to target this issue. The project will run from Apr 15, 2025 through Apr 14, 2028 and is being performed in Australia. The University of Melbourne has a track record...
- The University of Melbourne was awarded a $768,263 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program. The grant will fund research on developing a novel inhibitor of ribosome biogenesis with antitumor activity in preclinical models of prostate cancer. The goal of the Military Medical Research and Development program is to transform military and public health through innovative medical research solutions. This award will...
- The Department of Defense's Defense Health Agency has awarded a $506,785 Project Grant to the University of Queensland in Australia to conduct research on "PREDICTING EARLY-STAGE MELANOMA AT HIGH RISK OF RECURRENCE THROUGH MULTIOMICS PROFILING". This grant is funded under the Military Medical Research and Development program (CFDA 12.420), which supports advanced biomedical research to transform healthcare for military service members, veterans, and the broader public. The research...
- The University of Melbourne was awarded an $854,195 project grant from the Department of the Army Medical Command under the Military Medical Research and Development program. The grant will support integrative molecular characterization and biomarker validation research in metastatic hormone-sensitive prostate cancer from September 2021 through August 2025. Through this funding, the University of Melbourne will conduct basic, applied, and advanced biomedical research to investigate medical...
- The Defense Health Agency awarded a $744,997 Project Grant to the University of Queensland in Australia under the Military Medical Research and Development program (CFDA 12.420). This grant, titled "DISCOVERING THERAPEUTIC VULNERABILITIES OF CIRCULATING MELANOMA CLUSTERS," provides funding for the university to conduct cutting-edge biomedical research on melanoma from June 1, 2024 through May 31, 2027. The University of Queensland, a leading research institution in Australia, has an...
- The Defense Health Agency awarded a $697,766 Project Grant under the Military Medical Research and Development program (CFDA 12.420) to the Murdoch Children's Research Institute in Australia. The grant, awarded on July 15, 2024, will fund a 3-year research project titled "BRAIN CHARTS IN CHILDREN AND ADOLESCENTS WITH NEUROFIBROMATOSIS TYPE 1". The project aims to conduct biomedical research to better understand and characterize brain development in children and adolescents with...